Susceptibility to SARS-CoV-2 omicron following ChAdOx1 nCoV-19 and BNT162b2 versus CoronaVac vaccination

Susceptibility to SARS-CoV-2 omicron following ChAdOx1 nCoV-19 and BNT162b2 versus CoronaVac vaccination

The emergence of SARS-CoV-2 variants raises concerns of reduced COVID-19 vaccine efficacy. We investigated the humoral immunity in uninfected and previously infected ChAdOx1 nCoV-19, BNT162b2 and CoronaVac vaccinees, who have received complete regimes of vaccines by means of a SARS-CoV-2 surrogate v...

Full description

Bibliographic Details
Main Authors:	Chua, Jia Xin, Durrant, Lindy Gillian, Chok, Yin Ling, Lai, Oi Ming
Format:	Article
Published:	Cell Press 2022

Similar Items

Central retinal vein occlusion post ChAdOx1 nCoV-19 vaccination - can it be explained by the two-hit hypothesis?
by: Parakh, Shweta, et al.
Published: (2023)

Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report
by: Tan, Wee Yong, et al.
Published: (2021)

Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals
by: Goh, Yun Shan, et al.
Published: (2023)

Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age
by: Tan, Sharon H. X., et al.
Published: (2023)

Evaluation of genscript cpass and immusafe covid+ assays in detection of sars-cov-2 neutralising antibody titres in coronavac second and BNT162b2 booster doses
by: Izani, Wani Husna Mohd
Published: (2023)

Clinical course, immunogenicity, and efficacy of BNT162b2 mRNA vaccination against SARS-CoV-2 infection in liver transplant recipients
by: Tan, Eunice X., et al.
Published: (2024)

Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB
by: Chang, Zi Wei, et al.
Published: (2023)

The impact of novel coronavirus (2019-nCoV) pandemic movement control order (MCO) on dengue cases in Peninsular Malaysia
by: Rahim, Mohd Hafiz, et al.
Published: (2021)

BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study
by: Yung, Chee Fu, et al.
Published: (2024)

Whole genome sequencing analysis of SARS-CoV-2 from Malaysia: from alpha to Omicron
by: Choo, Yee Yu, et al.
Published: (2022)

12V car battery to 230VAC power inverter
by: Hazlan, Md. Rosdan
Published: (2009)

Prognostic factors for the outcomes of COVID-19 patients infected with SARS-CoV-2 Omicron and Delta variants
by: Gunadi, Gunadi, et al.
Published: (2023)

Rapid displacement of SARS-CoV-2 variant Delta by Omicron revealed by allele-specific PCR in wastewater
by: Lee, Wei Lin, et al.
Published: (2023)

Rapid displacement of SARS-CoV-2 variant Delta by Omicron revealed by allele-specific PCR in wastewater
by: Lee, Wei Lin, et al.
Published: (2023)

Autoimmune sequelae after Delta or Omicron variant SARS-CoV-2 infection in a highly vaccinated cohort
by: Wee, Liang En, et al.
Published: (2024)

The Persistence of Antibodies in ESRD Patients 12 Months after the BNT162b2 Vaccine Booster Dose.
by: Ummu Afeera, Zainulabid, et al.
Published: (2024)

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
by: T. Selvavinayagam, Sivaprakasam, et al.
Published: (2022)

mRNA booster vaccination enhances antibody responses against SARS-CoV2 omicron variant in individuals primed with mRNA or inactivated virus vaccines
by: Zhang, Biyan, et al.
Published: (2022)

Implanting CoOx clusters on ordered macroporous Zno nanoreactors for efficient CO₂ photoreduction
by: Wang, Yan, et al.
Published: (2023)

The SARS-CoV-2 variants and their impacts
by: Akmal Shukri, Amir Muhaimin, et al.
Published: (2022)

Expert System for Diagnosis of MERS-CoV
by: Reksoatmodjo, Wahyuni
Published: (2014)

Oxidation behaviour of FeCo-2V
by: Lam, Zanni Xing Chen
Published: (2022)

Lower vaccine-acquired immunity in the elderly population following two-dose BNT162b2 vaccination is alleviated by a third vaccine dose
by: Renia, Laurent, et al.
Published: (2023)

Reactive sputtering of CoZrTaOx thin films
by: Zheng, Cheng
Published: (2022)

Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor
by: Chia, Wan Ni, et al.
Published: (2023)

First SARS-CoV-2 Omicron infection as an effective immune booster among mRNA vaccinated individuals: final results from the first phase of the PRIBIVAC randomised clinical trial
by: Poh, Xuan Ying, et al.
Published: (2024)

Pathophysiology, histopathology and therapeutic of SARS-CoV-2
by: Noman, Efaq, et al.
Published: (2020)

Lateral flow immunoassays for SARS-CoV-2
by: Ang, Geik Yong, et al.
Published: (2022)

SARS-CoV-2-specific ELISA development
by: Roy, Vicky, et al.
Published: (2021)

Optimal design of corona ring for 132 kV insulator at high voltage transmission lines based on optimisation techniques
by: Kalaiselvi Aramugam, et al.
Published: (2023)

Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics
by: Chakraborty, Hirak, et al.
Published: (2021)

Evaluation of genscript cpass and immusafe covid+ assays for the detection of neutralizing antibody titers against sars-cov-2 in individuals with second and booster doses of BNT162b2
by: Salleh, Faraazlin
Published: (2023)

Decoding Covid-19 with the SARS-CoV-2 genome
by: Ellis, Phoebe, et al.
Published: (2021)

Development of SARS-CoV-2 Vaccine: Challenges and Prospects
by: Tooba Mahboob, et al.
Published: (2023)

Structure, reactivity, and electronic properties of V-doped Co clusters
by: Datta, Soumendu, et al.
Published: (2010)

Travel vaccination mapping application (VacMAP)
by: Goh, Chun Yi
Published: (2021)

Enhancing photoelectrochemical performance of the printed nanoporous FeVO₄ photoanode by dual-layer CoOₓ–CoPi catalysts
by: Nguyen, Thi Hiep, et al.
Published: (2023)

Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India—A state-wide prospective longitudinal study
by: Selvavinayagam, Sivaprakasam T., et al.
Published: (2024)

COVID-19 infection after SARS-CoV-2 mRNA vaccination in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD patients during the Omicron subvariant BA.1/2 wave in Singapore
by: Yeo, Tianrong, et al.
Published: (2023)

SARS-CoV-2 screening must go beyond sick
by: Abdullah, Syahril
Published: (2020)